BioXcel Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
BioXcel Therapeutics, Inc. (BTAI) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-13
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $1.42M.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $6.17M.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $2.54M, a 1170.00% increase from fiscal 2023.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $200.00K, a 93.84% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $3.25M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $7.59M 10-Q · filed 2026-08-13 | $7.59M derived: sum of 3 quarters · filed 2026-08-13 | $7.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.17M 10-Q · filed 2026-05-15 | $6.17M derived: sum of 2 quarters · filed 2026-05-15 | $6.17M derived: sum of 3 quarters · filed 2026-05-15 | $6.17M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $2.32M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $2.32M derived: sum of 3 quarters · filed 2026-08-13 | $2.32M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $2.32M derived: sum of 2 quarters · filed 2026-05-15 | $2.32M derived: sum of 3 quarters · filed 2026-05-15 | $2.32M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.32M derived: sum of 2 quarters · filed 2026-03-27 | $2.32M derived: sum of 3 quarters · filed 2026-03-27 | $2.54M 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $224.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $224.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $224.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $200.00K 10-K · filed 2025-03-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $3.25M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | $3.25M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $3.25M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |